HBK Investments’s Boston Scientific BSX Stock Holding History

HBK Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,900	Closed	-$500K	–	848
2020 Q4	$500K	Buy	+13,900	New	+$501K	﹤0.01%	579

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

HBK Investments's BSX Position: Q1 2020 in Review

HBK Investments sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 6,435 shares — an estimated $291K sold.

HBK Investments first reported a position in BSX in Q2 2013 and held it in 13 quarters. The position peaked at $17.3M in Q1 2018. 801 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

HBK Investments reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
HBK Investments sold 6,435 Boston Scientific shares in Q1 2020, an estimated $291K.
HBK Investments first reported a position in Boston Scientific in Q2 2013 and held it in 13 quarters.
HBK Investments's Boston Scientific position peaked at $17.3M in Q1 2018.
801 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on HBK Investments's 13F filing for Q1 2020, filed 15 May 2020.